Franklin Limited Duration Income Trust Announces Final Results of Tender Offer
Mar 13, 2017 12:45 pm UTC| Business
SAN MATEO, Calif., March 13, 2017 -- Franklin Limited Duration Income Trust (NYSE MKT:FTF), a closed-end investment company managed by Franklin Advisers, Inc., announced today the final results of its tender offer for...
Mar 13, 2017 12:45 pm UTC| Business
CHICAGO, March 13, 2017 -- Professional Diversity Network, Inc. (“PDN” or “the Company”) (NASDAQ:IPDN) today announced the appointment of Gary Xiao as its Chief Financial Officer, as well as its execution of employment...
Zealand hosts conference call on March 15 at 4 pm CET to present 2016 full-year results
Mar 13, 2017 12:42 pm UTC| Business
Press Release - No. 2 / 2017 Zealand hosts conference call on March 15 at 4 pm CET to present 2016 full-year results Copenhagen, March 13, 2017 - Zealand Pharma A/S ("Zealand") (CVR no. 20 04 50 78) announces that...
Opportunities in Board-Level Optical Interconnects: Current and Future Markets Analysis
Mar 13, 2017 12:38 pm UTC| Business
Dublin, March 13, 2017 -- Research and Markets has announced the addition of the "Opportunities in Board-Level Optical Interconnects: Optics-Enabled Circuit Boards, Optical Engines and Optical Backplanes"...
Patriot Transportation Holding, Inc. Announces Departure of Chairman and CEO
Mar 13, 2017 12:30 pm UTC| Business
JACKSONVILLE, Fla., March 13, 2017 -- Patriot Transportation Holding, Inc. (NASDAQ:PATI) today announced that Thompson S. Baker II, its Chairman and Chief Executive Officer, has resigned his CEO position to accept a new...
Acology Reports Upsurge in Global Sales, Projects Confidence in North American Market
Mar 13, 2017 12:30 pm UTC| Business
CORONA, Calif., March 13, 2017 -- Acology Inc. (OTC:ACOL) announced today that international orders continue to rise and that North American orders have remained strong despite some ambiguity in the political...
MyoKardia Reports Fourth Quarter and Full Year 2016 Financial Results and Operational Progress
Mar 13, 2017 12:30 pm UTC| Business
Topline Data from Phase 2 PIONEER-HCM Trial of MYK-461 in Symptomatic Obstructive Hypertrophic Cardiomyopathy Expected in Third Quarter of 2017MYK-491 Dilated Cardiomyopathy Candidate Phase 1 Study of Healthy Volunteers...